This is a summary of the European public assessment report (EPAR) for Intrarosa. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Intrarosa. For practical information about using Intrarosa, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Intrarosa is indicated for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.
Therapeutic Area (MeSH)
N/AATC Code
G03XX01
ATC Item
prasterone
Pharmacotherapeutic Group
Other sex hormones and modulators of the genital system
Active Substance (Summary)
INN / Common Names
N/AEMA Name
Intrarosa
Medicine Name
Intrarosa
Aliases
N/ANo risk management plan link.
